Gaddiel Rodriguez

Patent Agent II


Gaddiel Rodriguez is a Patent Agent in the Intellectual Property Department with Foley & Lardner LLP. Gaddiel is based in the Boston office where he is a member of the firm’s Chemical, Biotech, and Pharmaceutical Practice Groups.

Gaddiel is a patent agent with experience in patent application drafting and prosecution, freedom-to-operate analyses, due-diligence research, and market research. He specializes in in biomolecular sciences with extensive experience in pharmacological, biological, and biophysical methods.

Prior to joining Foley, Gaddiel worked at an international law firm where his practice focused on worldwide life sciences patent portfolio development, patent drafting and prosecution, IP due diligence, FTO/patentability analysis, and support for litigation/PTAB proceedings.


  • Research Supplement to Promote Diversity in Health-Related Research – US NIH/NIGMS
  • Minority Access to Research Careers (MARC) – US NIH/NIGMS

Presentations and Publications

  • Rodriguez G, et al. “Disordered N-Terminal Domain of Human Uracil DNA Glycosylase (hUNG2) Enhances DNA Translocation.” ACS Chem Biol, 12, (2017): 2260-2263
  • Coauthor, “Measurement of Nanoscale DNA Translocation by Uracil DNA Glycosylase in Human Cells.,” Nucleic Acids Res, 45, 12413 (2017)
  • Coauthor, “AP-Endonuclease 1 Accelerates Turnover of Human 8-Oxoguanine DNA Glycosylase by Preventing Retrograde Binding to the Abasic-Site Product.” Biochemistry, 56, 1974 (2017)
  • Coauthor, “N-terminal Domain of Human Uracil DNA Glycosylase (hUNG2) Promotes Targeting to Uracil Sites Adjacent to ssDNA-dsDNA Junctions.” Nucleic Acids Res, 46, 7169 (2018)
  • Rodriguez G, et al. “Macromolecular crowding induces compaction and DNA binding in the disordered N-terminal domain of hUNG2.” DNA repair, 86, (2020): 102764


  • Johns Hopkins University School of Medicine, Baltimore, MD (PhD, 2019)
    • Biochemistry/Chemistry


  • United States Patent and Trademark Office